Australian Government - Austrade


Go to international website
Search Click to start search
Username   Password  Remember me Click to Login
Join  Forgotten Password?  Contact Us 
You are here:
Malaysia

Health and medical to Malaysia

Click to send this to a friendClick to print pageClick to print page to PDFContact usChange to standard fontChange to large font

(Last updated: 8 Sept 2008)

Trends and opportunities

The market

Healthcare in Malaysia is catered both by public and private providers. The government is still the main provider as healthcare in the country is still heavily subsidised. Private healthcare cost is fully borne by patients themselves or through their insurers.


The 9th Malaysian Plan (9MP) outlines the government strategies and focus for the healthcare industry for the next five years (2006-2010). Under 9MP, the thrust towards achieving greater health will be through various goals, including preventing and reducing disease and enhancing healthcare delivery.
 

Does this mean that within this period the Malaysian National Healthcare Financing Scheme (similar to Australia’s Medicare system) will finally be implemented? Per the industry feedback, government will have to do so very soon as the escalating healthcare costs is creating a burden too great for them to bear.


Basic healthcare information for Malaysia:

Population (2006)

 26.3 million 

No. of doctors  21,937
No. of pharmacists  4,292
No. of nurses  47,642
No. of hospitals (public & private)  373
No. of hospital beds     50,262
(Source: Ministry of Health)

There has been rapid growth in number of private hospitals in the last two decades. In 1980, there were only about 50 private hospitals with 2000 beds. Currently there are more than 233 private hospitals with more than 11,000 beds.


 

The larger private health groups in Malaysia are Johor Healthcare Group and Pantai Group of Hospitals

Private hospitals are no longer concentrated in the cities only, as the increase in population number has driven the growth of private centres into many of the bigger towns in the country, with populations of 200,000 or more.

The growth of private hospitals also contributed to the shortage faced by the public sector. Almost 40 per cent of practising doctors serve in the private sector.

The current ratio of doctors per population is 1:1200, which is still far from the national target of 1:600 by 2020 and similarly ambitious targets for nurses (current ratio 1:560) and other medical personnel. To achieve this, a number of expansion strategies are being pursued. This includes:

  • The recruitment of foreign doctors and specialists.
  • Acknowledging foreign medical degrees formerly not recognised (with conditions attached).
  • An increase in the number of scholarships for local and foreign training of Malaysian doctors. 
  • The establishment of new medical colleges and twinning programs.

Construction activities in the public sector for the next five years are expected to slow down even more with the escalating costs and ‘runaway’ inflation rates. Required infrastructures are mostly in place, thus construction of new hospitals are only limited to those which were ‘postponed’ from the 7th and 8th Malaysian Plan. These include the Women & Children’s Hospital, rehabilitation hospital and psychiatric hospitals and refurbishments of state/district hospitals.

Private hospitals construction is also limited in numbers, with only a couple of on-going projects for new hospitals. Most major hospitals have already completed their expansion programs or have put on hold new construction.

 

Pharmaceuticals

With pharmaceutical, generic and OTC manufacturing, there are approximately 72 manufacturers in Malaysia licensed by the Drug Control Authority. Around 30 are licensed to manufacture prescription medicines, while the rest produce iver-the-counter medicines. Another 130 manufacturers produces traditional and herbal medicines.


The Malaysian drug market was valued at approximately US$1.1 billion last year, with an 11 per cent annual growth rate for the next five years. The majority of patented drugs are still imported as pharmaceutical multi-nationals control approximately 70 per cent of the market. The rest are in demand for generic and OTC products, which is catered for mostly by local manufacturers.


Due to a lack of pharmacists, Malaysia is still a doctors prescribing market.  

Opportunities

Ninety per cent of medical equipment used in Malaysia is imported. Although Australia is not the main supplier of medical equipment, Australian companies have been successful in penetrating this market with their offerings of innovative/niche medical products and services. 


In a few years, we have seen the trend of Australian health/medical offerings changing and leaning towards provision of services. The tie-up of Australian universities offering health-related courses in Malaysia is one of the best examples. Others include allied health skilled training, ambulance service operations and retirement village planners.


Opportunities exist in the following areas:

  • Training and specialised medical education for healthcare personnel (nursing, paramedical and management programs)
  • Innovative/specialised/niche medical equipment
  • Health IT systems and services
  • Health consulting services
  • Contract manufacturing of generics and OTC products
back to top of site

Tariffs, regulations and customs

Industry standards

Malaysian tariffs vary for medical equipment and disposables. Most imported medical equipment is not subjected to tax. Import tax for complementary products (eg. hospital beds and spare parts) ranges from zero to 30 per cent of the products value. Some products have additional sales tax ranging from zero to 10 per cent.

It should be noted that X-ray/laser equipment requires an import license, which must be applied for by the importer (which should be a Malaysian company).


At present, Malaysia does not yet have medical device regulations. However, they have started with a voluntary registration of medical devices distribution companies since 1997. As for equipment, the government has worked to prepare and ultimately implement a system that is aligned to the ASEAN Harmonisation Working Party and the Global Harmonisation Work Force guidelines. The Medical Devices Act is ready and awaiting its day to be presented at the Malaysian parliamentary sitting.

back to top of site

Marketing your products and services

Market entry

The various channels of entry into the Malaysian health industry are:

  • Direct marketing by principal companies (eg. Johnson & Johnson, 3M, Braun, etc.)
  • Sales through local agents or distributors
  • Sales through trading houses
  • Direct sales to re-sellers (eg. pharmacies, rehabilitation centres)
  • Direct sales to end users (eg. hospitals, clinics, medical practitioners)

Direct export is the most common entry strategy in the provision of services. This includes management, consultancy and training programs. These export transactions are concluded through direct negotiations with end customers.


For indirect exports, establishing a local presence is important and there are various ways to do this:

  • Appoint an agent or distributor
  • Form a joint venture partnership
  • Form short-term partnership (ie. one or two year contract with opportunity to review the partnership at the end of each term)
  • Form ‘ad-hoc’ partnership (ie. different partners for different projects)
  • Set up a local office

Malaysian companies are very open and receptive to new products and services. The following suggestions are for Australian companies who are interested in marketing their products and services:

  • Be prepared to visit the Malaysian healthcare sector regularly (at least two to three times a year).
  • Follow up on previous visits (through telephone, email or faxes).
  • Learn about the cultural issues in Malaysia.
  • Prepare information packs about your company, products and services offered.
  • It is preferable to have a local agent or distributor.
back to top of site

Links and industry contacts

Government, business and trade resources for Malaysia: 

Association of Private Hospitals of Malaysia – www.hospitals-malaysia.org

Kumpulan Perubatan (Johor) Sdn Bhd – www.kpj.com.my
Malaysian Medical Association – www.mma.org.my
Ministry of Health Malaysia – www.moh.gov.my
Malaysian Industrial Development Authority – www.mida.gov.my
National Pharmaceutical Control Bureau – www.bpfk.gov.my
Pantai Holdings Bhd – www.pantai.com.my

back to top of site

Contact details

The Australian Trade Commission (Austrade) is the Australian Government’s trade and investment development agency, operating as a statutory agency within the Foreign Affairs and Trade portfolio.

Austrade assists Australian businesses contribute to national prosperity by succeeding in trade and investment, internationally, and promoting and supporting productive foreign investment into Australia.

Austrade:

  • Delivers services that assist Australian businesses initiate, sustain and grow trade and outward investment.
  • Promotes Australia as an inward investment destination and, with the States and Territories, supports the inflow of productive foreign direct investment.
  • Administers the Export Market Development Grants scheme.
  • Undertakes initiatives designed to improve community awareness of, and commitment to, international trade and investment.
  • Provides advice to the Australian Government on its trade and investment development activities.
  • Delivers consular, passport and other government services in designated overseas locations.

A list of Austrade offices (in alphabetical order of country) is available.

More information

For further information please contact Austrade on 13 28 78 or email info@austrade.gov.au

back to top of site

Share this content

Sidebar Content

Export Update

Austrade's monthly eNewsletter bringing you all the latest export-related news and events within Australia and overseas.

Export Opportunities

Register on the online database - a useful tool in identifying international business leads to support your firm’s export strategy.

Case studies

Austrade has profiled over  100 companies from a range of industries and markets, all over Australia. Read these case studies.

     

Footer Information

Economist's Corner | Publications | Student Centre | Employment | DFAT | Minister for Trade | Contact Us | RSS/XML Feeds
Privacy Disclaimer | Technical Info | Site Disclaimer | Linking Policy | Site Map | Useful Websites | FAQs | Blogs

Disclaimer

Austrade makes no warranty, express or implied as to the fitness for a particular purpose, or assumes any legal liability for the accuracy or usefulness of any information contained in this document. Any consequential loss or damage suffered as a result of reliance on this information is the sole responsibility of the user.